Society for Immunotherapy of Cancer (SITC)
November 1 - 5, 2023

Society for Immunotherapy of Cancer (SITC)

Location: San Diego, California

Pangea presented a poster on the predictiveness of ENLIGHT technology.  
ARC Summit 2023
June 15, 2023

ARC Summit 2023

Location: Tel Aviv, Israel

CEO Tuvik Beker gave a presentation about ENLIGHT at the ARC summit in Tel Aviv, Israel.
Read More arrow arrow
BIO International Convention 2023
June 6 - 7, 2023

BIO International Convention 2023

Location: Boston, Massachusetts

COO Emmanuel Elalouf attended the Bio International Convention in Boston to meet with industry leaders and executives.
American Society of Clinical Oncology 2023
June 4 - 5, 2023

American Society of Clinical Oncology 2023

Location: Chicago, Illinois

Our CTO Ranit Aharonov and COO Emmanuel Elalouf attended ASCO 2023. Ranit presented two posters: one on our ENLIGHT technology and the other on the ENLIGHT-DP framework.
Read More arrow arrow
Biomed Israel 2023
May 16 - 18, 2023

Biomed Israel 2023

Location: Tel Aviv, Israel

Our CEO Tuvik Beker gave a presentation on ENLIGHT at Biomed Israel 2023.
Read More arrow arrow
American Association of Cancer Research 2023
April 14 - 19, 2023

American Association of Cancer Research 2023

Location: Orlando, Florida

Our CEO Tuvik Beker and Head of Research Gal Dinstag attended AACR to connect with leading oncology executives. Gal presented two posters on ENLIGHT and the ENLIGHT-DP framework.
Read More arrow arrow
EACR-OECI Molecular Pathology Approach to Cancer
March 28 - 30, 2023

EACR-OECI Molecular Pathology Approach to Cancer

Location: Bergamo, Italy

Our CEO Tuvik Beker presented a talk titled, "ENLIGHT: Predicting response to cancer therapy based on gene expression patterns from RNAseq or H&E slides."
Read More arrow arrow
The New World of RNA Diagnostics and Therapeutics at the Elena Cancer Center
March 27 - 28, 2023

The New World of RNA Diagnostics and Therapeutics at the Elena Cancer Center

Location: Rome, Italy

CTO Ranit Aharonov presented a presentation titled, “Prediction of Cancer Treatment Response from Histopathology Images Through Imputed Transcriptomics.”
Read More arrow arrow
European Society for Medical Oncology 2022
September 9 - 13, 2022

European Society for Medical Oncology 2022

Location: Paris, France

Our CEO Tuvik Beker and COO Emmanuel Elaouf attended the conference to meet with industry leaders and executives.